It has also been shown that MCM2 overexpression is a poor prognostic factor in glioma, hepatocellular cancers, non-small cell lung cancer, acute lymphocytic leukemia, renal cell cancer and breast cancer.24 The gene discussed is MCM2; the disease is glioma.